Elsevier

The Lancet

Volume 395, Issue 10234, 2–8 May 2020, Pages 1407-1409
The Lancet

Comment
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

https://doi.org/10.1016/S0140-6736(20)30858-8Get rights and content

Cited by (0)

View Abstract